These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4730599)
41. Can neo-adjuvant chemotherapy prevent residual tumors? Bourut C; Chenu E; Mathé G Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):59-63. PubMed ID: 2743533 [TBL] [Abstract][Full Text] [Related]
42. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors. Mihich E; Gelzer J Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648 [No Abstract] [Full Text] [Related]
43. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Teller MN; Kaufman RJ; Bowie M; Stock CC Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416 [No Abstract] [Full Text] [Related]
44. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats. Reinhardt M; Heyl P; Amelung F; Berger MR Arzneimittelforschung; 1992 Oct; 42(10):1239-42. PubMed ID: 1282010 [TBL] [Abstract][Full Text] [Related]
45. [Transplantation of in vitro cultured human tumors to nude mice and their use as chemotherapeutic test models]. Naundorf B; Arnold W; Nissen E; Wildner GP Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):652-7. PubMed ID: 6172329 [No Abstract] [Full Text] [Related]
46. [Effect of antineoplastic agents on the hypophysis-ovarian system in rats with transplantable mammary neoplasms]. Vasnetsova SS; Bulkina ZP; Turkevich NM Vopr Onkol; 1971; 17(8):85-90. PubMed ID: 5002549 [No Abstract] [Full Text] [Related]
47. Effect of high dose of pyridoxine on mammary tumorigenesis. Shimada D; Fukuda A; Kawaguchi H; Kato N; Yoshida H; Kanouchi H; Oka T Nutr Cancer; 2005; 53(2):202-7. PubMed ID: 16573381 [TBL] [Abstract][Full Text] [Related]
48. Effect of surgery, hormones, and nutrition on mammary cancer induced by 3-methylcholanthrene in female Wistar rats. Gruenstein M; Thatcher D; Acuff M; Shimkin MB Cancer Res; 1966 Jun; 26(6 Pt 2):579-86. PubMed ID: 5939560 [No Abstract] [Full Text] [Related]
49. Effect of androgen depletion on growth and androgen dependency of Shionogi carcinoma 115. Kitamura Y; Okamoto S; Uchida N; Yamaguchi K; Matsumoto K Cancer Res; 1978 Dec; 38(12):4711-6. PubMed ID: 719647 [No Abstract] [Full Text] [Related]
50. Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts. Bogden AE; Kelton DE; Cobb WR; Gulkin TA; Johnson RK Cancer Res; 1978 Jan; 38(1):59-64. PubMed ID: 618583 [No Abstract] [Full Text] [Related]
51. [The anti-tumor effectiveness of hormones in rat mammary gland neoplasms]. Beskrovnyĭ AM Vopr Onkol; 1971; 17(9):95-8. PubMed ID: 5138815 [No Abstract] [Full Text] [Related]
52. Effect of androgen depletion on postoperative regrowth of androgen-dependent and -independent Shionogi carcinomas in mice. Narita N; Nakao K; Uchida N; Yamaguchi K; Okamoto S; Kitamura Y; Matsumoto K Gan; 1980 Aug; 71(4):501-6. PubMed ID: 7429087 [TBL] [Abstract][Full Text] [Related]
53. Effects of treatment with cyclophosphamide on hormone-dependent and hormone-independent tumor cells in transplanted GR mouse mammary tumors. Sluyser M; Benckhuysen C Cancer Treat Rep; 1977 Aug; 61(5):861-7. PubMed ID: 890694 [TBL] [Abstract][Full Text] [Related]
54. Biochemical studies of hormone-responsive mammary tumors. Hilf R Cancer Res; 1968 Sep; 28(9):1888-90. PubMed ID: 5676740 [No Abstract] [Full Text] [Related]
55. [Sex chromatin in different endocrine functions--clinical studies and experimental studies of animals]. Yamana K Endokrinologie; 1964 Nov; 47(1):63-78. PubMed ID: 5836933 [No Abstract] [Full Text] [Related]
56. Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries. Welsch CW; Jenkins TW; Meites J Cancer Res; 1970 Apr; 30(4):1024-9. PubMed ID: 5504344 [TBL] [Abstract][Full Text] [Related]
57. [Inhibitory effect of a thymic polypeptide factor on the development of mammary gland adenocarcinoma induced by 7,12-dimethylbenz(a)anthracene in female rats]. Anisimov VN; Danetskaia EV; Morozov VG; Khavinson VKh Dokl Akad Nauk SSSR; 1980; 250(6):1485-7. PubMed ID: 6769657 [No Abstract] [Full Text] [Related]
58. [Oncobiogram and therapy success in transplantation neoplasms]. Volm M; Bastert G; Mattern J; Wayss K Naturwissenschaften; 1973 Aug; 60(8):395. PubMed ID: 4745555 [No Abstract] [Full Text] [Related]
59. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations]. Maliugina LL; Pol'kina RI Vopr Onkol; 1974; 20(3):62-9. PubMed ID: 4439803 [No Abstract] [Full Text] [Related]
60. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors. Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]